Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Ibrutinib and R-da-EPOCH for Front Line Treatment of AIDS-Related Lymphomas

NCT03220022 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03220022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03220022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Ibrutinib and R-da-EPOCH for Front Line Treatment of AIDS-Related Lymphomas
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 16, 2018
Completion date
July 16, 2027
Enrollment
46 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

aids-related lymphoma, ann arbor stage ii diffuse large b-cell lymphoma, ann arbor stage iii diffuse large b-cell lymphoma, ann arbor stage iv diffuse large b-cell lymphoma